OBJECTIVE: Shorter sleep duration predisposes to obesity, but the mechanisms whereby sleep deprivation affects body weight are poorly understood. We tested whether this association is modulated by the obesity genes FTO, TMEM18 and NRXN3. SUBJECTS: Body mass index (BMI), waist circumference, visceral fat (abdominal ultrasound), homeostasis model assessment for insulin resistance (HOMA-IR), systolic blood pressure (SBP) and sleep time per 24 h were assessed in 297 asymptomatic children (151 boys, 146 girls; age range 5 --9 years; BMI s.d. score range À2.0 --4.0). Associations between sleep duration and the abovementioned outcomes were tested for three common single-nucleotide polymorphisms (SNPs), namely FTO (rs9939609), TMEM 18 (rs4854344) and NRXN3 (rs10146997), as well as for their combination. RESULTS: TT homozygotes (but not A* carriers) for the FTO SNP, exhibited nominal associations between decreasing sleep duration and increasing BMI, waist circumference, visceral fat and HOMA-IR (all Po0.05). Similar associations were observed in children with risk alleles (but not in those without risk alleles) for the TMEM18 and NRXN3 SNPs (Po0.05 to Po0.0001). The three SNPs had additive effects on the negative associations between sleep and, respectively, BMI (Po0.001), waist (Po0.005), visceral fat (Po0.001), HOMA-IR (P ¼ 0.010) and SBP (Po0.0005). The combined effects on obesity measures and SBP remained significant after correction for multiple testing. On an average, 2 h of sleep less per night was associated with an increase in BMI of 1.0 s.d. (95% confidence interval 0.5--1.6 s.d.) and with 8.0 cm (95% confidence interval 3.6--12.2 cm) more waist circumference in genetically susceptible children. CONCLUSION: By age 7, common variations in FTO, TMEM18 and NRXN3 influence the vulnerability to metabolic complications of sleep deprivation. Further genetic studies are warranted to replicate these findings in other populations.
INTRODUCTION
The epidemic of childhood obesity has developed over the same time period as the progressive decrease in self-reported sleep duration. 1, 2 Studies have suggested that alterations in sleep time could lead to food intake deregulation, obesity and cardiovascular disease. 3, 4 Even acute sleep deprivation can cause increases in appetite, insulin resistance and inflammatory markers in humans. 5, 6 Genome-wide association studies have provided evidence that variations in FTO, TMEM18 and NRXN3 genes are related to obesity. 7 --9 These genes are all predominantly expressed in the brain. 9 --11 FTO has been described as a demethylase for single-stranded DNA and RNA 12 that has important roles in energy balance. 13, 14 The non-risk T allele in rs9939609 of FTO is related to lower expression of FTO and protection from obesity. 15 Another gene that participates in the appetite-signaling system is TMEM18. Notably, obesity studies uncovered TMEM18 as the second in significance to FTO. 16 The T allele for the rs4854344 single-nucleotide polymorphism (SNP) in TMEM18 has been associated with the obese phenotype. 8, 17 NRXN3 is part of a family of central nervous adhesion molecules. The gene was previously associated with addiction and reward behavior, and is a compelling biological candidate for obesity. 18, 19 The risk of obesity is higher among G allele carriers for the rs10146997 SNP in the NRXN3 gene. 9 It is believed that environmental factors interact with the genetic background to influence body weight. 20 Consequently, we hypothesized that obesity genes may modulate the susceptibility to weight gain induced by shorter sleep duration and assessed whether this association may be mediated by common SNPs in FTO, TMEM18 and NRXN3 in asymptomatic children.
SUBJECTS AND METHODS

Population and ethics
The study group consisted of 297 school-aged Caucasian children (151 boys, 146 girls; age range 5 --9 years; BMI s.d. score range À2.0 --4.0) included in an ongoing population-based study of cardiovascular risk factors in children. Subjects were consecutively recruited among those seen within a setting of preventive medicine in the Alt Empordà and Girona, both regions in the Northern Spain. Participation ranged from 50--70% in the different study centers.
Inclusion criteria were as follows: (1) age between 5 and 9 years; (2) no pubertal development, as judged by Tanner criteria (breast stage I; testicular volume o 4 ml). Exclusion criteria were as follows: (1) major congenital abnormalities; (2) abnormal blood counts, liver or kidney or thyroid functions; (3) evidence of chronic illness or chronic use of medication and (4) acute illness or use of medication in the month preceding potential enrolment.
The research was approved by the Institutional Review Board of Dr Josep Trueta Hospital. Signed consent was obtained from the parents.
Clinical assessments
Clinical examination was performed in the morning, in the fasting state followed by venous blood sampling. Weight was measured wearing light clothes with a calibrated scale and height was measured with a Harpenden stadiometer. Body mass index (BMI) was calculated as weight divided by the square of height in meters. Age-and sex-adjusted s.d. scores for BMI were calculated using regional normative data. 21 Waist circumference was measured in the supine position at the umbilical level.
Blood pressure was measured in the supine position on the right arm after a 10-min rest; an electronic sphygmomanometer (Dinamap ProCare 100, GE Healthcare, Chalfont St Giles, UK) with cuff size appropriate for arm circumference was used.
The body composition was assessed by bioelectric impedance (Hydra Bioimpedance Analyzer 4200, Xitron Technologies, San Diego, CA, USA). Fat mass was calculated as the difference between weight and lean mass.
Visceral fat
In a subset of children (n ¼ 199; 97 boys, 102 girls) who agreed to participate further in the study and whose clinical characteristics did not diverge from the whole group, visceral fat was measured by highresolution ultrasonography (MyLab25, Esaote, Firenze, Italy).
Visceral fat was estimated as the distance between the internal surface of the abdominal wall and the posterior wall of the aorta at the umbilical level. 22 The thickness of the fat layer of the posterior right renal wall in the perinephric space was also calculated and added to the visceral fat measurement. Images were obtained in the fasting state, in the supine position at the end of a normal exhalation, using a convex 3.5 MHz transducer. Averages of five measurements of each parameter were used in this study. Intra-subject coefficient of variation for ultrasound measurements was o 6%.
Questionnaires
Sleep time, nutrition and physical activity were assessed by selfadministered questionnaires. Hours of daily sleep were calculated as the average of total hours of sleep in a 24-h period. Dietary intakes were estimated from self-reported consumption of food during a week; the questionnaire has been validated in children. 23 Physical activity was measured using metabolic equivalent intensity levels (METs) for different self-reported activities. 24 For each activity, a crude estimate of its relative intensity was derived by multiplying the average hours per day by the metabolic cost of that activity, following the information described in the Compendium of Physical Activities, 25, 26 and was expressed in MET h. 27 Family history of obesity was assessed by a self-administered questionnaire. Obesity was diagnosed in the parents if their BMI was X30 kg/m 2 . Subjects were classified as having a positive history for obesity if at least one parent was affected by the disease.
Laboratory variables
All serum samples were obtained between 0800 and 0900 hours under fasting conditions. Serum glucose was analyzed by the glucose hexoquinase method. Serum immunoreactive insulin was measured by immunochemiluminiscence (IMMULITE 2000, Diagnostic Products, Los Angeles, CA, USA). Lower detection limit was 0.4 mIU/l and intraand inter-assay coefficient of variances were o10%. Insulin resistance was calculated using the homeostasis model assessment for insulin resistance (HOMA-IR ¼ (fasting insulin in mU/l) Â (fasting glucose in mM)/22.5). HMW adiponectin was measured by a sandwich ELISA (Linco, St Charles, MO, USA). The detection limit was 0.5 ng/ml and coefficient of variance was o4%. Total serum triglycerides were measured by monitoring the reaction of glycerol-phosphate oxidase. High-density lipoprotein cholesterol was quantified by the homogenous method of selective detergent with accelerator.
Genetic analysis
Genomic DNAs were extracted from peripheral blood leukocytes using the QIAamp DNA mini kit (Qiagen Inc., Valencia, CA, USA), following the standard protocol. Total DNA was eluted in 50-ml nuclease free water and aliquoted for storage at À20 1C. Total DNA concentration was calculated by means of a nanophotometer (NanoPhotometer Pearl, IMPLEN, Mü nchen, Germany). Allelic discrimination was performed using TaqMan SNP genotyping assays (rs9939609 for FTO, rs4854344 for TMEM18 and rs10146997 for NRXN3) on an ABI PRISM 7000 Real Time PCR apparatus (Applied Biosystems, Foster City, CA, USA) using the default cycling conditions.
To assess the combined genetic influence of these obesity genes, the study population was ranked in two groups (p3 and 43) by a polymorphism score, the latter being the sum of 3 subscores, each corresponding to each of the studied SNP. A subscore of 1 was given per each T allele in FTO, per each T allele in TMEM18 and per each G allele in NRXN3.
Statistics
Statistical analyses were performed using the SPSS version 12.0. (SPSS Inc., Chicago, IL, USA). Results are expressed as mean ± s.e.m. Non-parametric variables were mathematically transformed, either by logarithmic or by square root transformation, to improve symmetry. The relation between Visceral fat was measured in a subset of 199 children (51.3% girls).
Obesity genes and sleep duration A Prats-Puig et al variables was analyzed by simple correlation followed by multiple regression analysis in a stepwise manner. General lineal models were used to study the effect of the genetic score on obesity-related traits. A statistical significance for nominal associations was set at Po0.05. A Bonferroni correction (conventional P-value of 0.05 divided by 12 (product of four independent outcomes and three SNPs), yielding a corrected P-value p0.004) was also applied to the results of this study to account for multiple testing.
RESULTS
Anthropometric and metabolic characteristics of the study subjects (n ¼ 297; 151 boys and 146 girls) are shown in Table 1 .
Bivariate analyses
In the studied subjects, BMI, waist circumference and visceral fat nominally increased with decreasing sleep duration ( Table 2) .
Although the studied SNPs in FTO, TMEM18 and NRXN3 were unrelated to sleep duration (mean daily sleep was between 9.7 and 9.8 h for all genotypes), significant interactions were evident for these SNPs, alone or in combination, on the association between sleep duration and obesity-related traits.
Decreased sleep duration was related to a less favorable metabolic profile in TT homozygotes, but not in A* carriers for the rs9939609 SNP in FTO, with nominal associations between shorter sleep duration and increased BMI, waist circumference, visceral fat, HOMA-IR and systolic blood pressure (SBP) in the former, but not the latter subjects (all Po0.05; Table 2 ).
Carriers of risk alleles for the rs4854344 SNP in TMEM18 and rs10146997 SNP in NRXN3, but not those children with other genotypes, showed also nominal associations between shorter sleep duration and increased BMI, waist circumference, visceral fat, HOMA-IR (NRXN3 carriers only) and SBP (Po0.05 to Po0.0001; Table 2 ).
Additive effects were observed for these common polymorphisms on the negative association between sleep length and obesity-associated traits, so that subjects with a polymorphism score 43 had the strongest associations between shorter sleep duration and, respectively, BMI (P ¼ 0.001), waist (P ¼ 0.001), visceral fat (P ¼ 0.006), HOMA-IR (P ¼ 0.010) and SBP (P ¼ 0.015; Table 2 ). 
Multivariate analyses
Results were confirmed in multiple regression analyses adjusting for age, gender, nutrition and physical activity scores and family Visceral fat was measured in a subset of 199 children.
Obesity genes and sleep duration A Prats-Puig et al history of obesity (Table 3) . Nominal associations between short sleep duration and obesity-associated traits were shown in children with a polymorphism score 43, including those for BMI (Po0.001), waist (Po0.005), visceral fat (P ¼ 0.001), HOMA-IR (P ¼ 0.010) and SBP (Po0.0005; Table 3 ). The combined effects on obesity measures and SBP remained significant after correction for multiple testing.
DISCUSSION
We herein report new evidence for an interaction between environmental and genetic factors in the modulation of body weight. We show for the first time that a genetic score of common SNPs in the obesity genes FTO, TMEM18 and NRXN3 influence the susceptibility of children to weight gain induced by short sleep duration. Previous longitudinal studies on the relationship between sleep duration and body weight in children have described consistent effects of sleep deprivation on the risk of overweight and obesity. 28, 29 Our results concur with these reports by showing that shorter sleep duration is in asymptomatic prepubertal children related to higher BMI, waist circumference and visceral fat. However, the mechanisms for these associations are not completely understood. 30 Our results imply that variations in the expression and/or activity of the obesity genes FTO, TMEM18 and NRXN3 may be among the mechanisms whereby sleep duration influences body weight. Notably, these genetic interactions are evident without detectable effects of the selected SNPs on sleep duration, as recently reported for the rs9939609 SNP in FTO.
31
Shorter sleep duration was related to a number of obesityassociated traits in homozygous children with the non-risk TT genotype, but not in those carrying the risk A allele for the rs9939609 SNP in FTO. Although a number of authors have shown that it is the A allele that interacts on the association between physical activity and obesity, 32 --34 others have shown that it is the TT genotype that interacts on the association between physical activity and cardiovascular mortality. 35 Our results suggest that the protective effect of increased sleep duration on body weight Abbreviations: b, beta coefficient; BMI, body mass index; CI, confidence interval; HOMA-IR, homeostasis model assessment of insulin resistance; r 2 , squared of correlation coefficient; SBP, systolic blood pressure. Results are adjusted for age, gender, nutrition and physical activity scores and family history of obesity in general lineal models. Highlighted results are those that remained significant after correction for multiple comparisons (P-value p0.004; see text). Results are shown according to genotypes for FTO, TMEM18 and NRXN3. Obesity genes and sleep duration A Prats-Puig et al gain is only readily observable as long as there is low FTO expression, as in those with the TT genotype, 15 the effect of the FTO gene overriding that of sleep protection in subjects with higher gene expression, such as those carrying the A allele. In this respect, a low FTO expression in rodents has also been associated with changes in the food intake and energy expenditure. 36 On the other hand, it is the risk alleles in the obese genes TMEM18 and NRXN3 that appear to convey higher risk for obesity associated with shorter sleep duration. Although TMEM18 has been shown to regulate food intake, 37 NRXN3 has been implicated in alcohol dependence and illegal substance abuse 18, 19 and may thus also be implicated in the regulation of food intake. It is well known that sleep deprivation could adversely affect selected endocrine functions and metabolic pathways, leading to decreased satiety and energy expenditure, and increased hunger, food cravings, and caloric intake in adults. 38, 39 A suitable sleep pattern could thus attenuate the adverse effects of common SNPs in TMEM18 and NRXN3 on the control of body weight. Finally, our results suggest additive effects for common SNPs in obesity genes on the negative association between shorter sleep duration and body weight, so that 2 h of shorter sleep per night was associated with remarkable changes in BMI (average 1s.d.) and waist circumference (average 8.0 cm) in genetically susceptible children.
We acknowledge a number of limitations in our study. Some of the nominal associations for sleep duration and obesity-associated traits did not remain significant after applying a Bonferroni correction for multiple testing. The relatively small number of subjects and the narrow age range of the studied children warrant further investigation, including replication studies in other populations, to confirm our findings. The results derived from questionnaires assessing sleep duration are only estimates as compared with those obtained by using more laborious methodologies, such as actigraphy or polysomnography. However, others have shown acceptable correlations between self-reported sleep duration and that measured by these techniques. 40, 41 In summary, we report evidence that genetic variations in the obesity genes FTO, TMEM18 and NRXN3 can modulate the vulnerability of children to weight gain related to short sleep duration.
